1. Home
  2. CTRE vs BLCO Comparison

CTRE vs BLCO Comparison

Compare CTRE & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

HOLD

Current Price

$36.18

Market Cap

7.4B

Sector

Real Estate

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.99

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRE
BLCO
Founded
2013
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Ophthalmic Goods
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
CTRE
BLCO
Price
$36.18
$16.99
Analyst Decision
Buy
Hold
Analyst Count
6
14
Target Price
$39.50
$17.31
AVG Volume (30 Days)
1.8M
408.9K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
3.69%
N/A
EPS Growth
90.43
N/A
EPS
1.34
N/A
Revenue
$428,478,000.00
$4,976,000,000.00
Revenue This Year
$23.27
$8.08
Revenue Next Year
$27.02
$5.77
P/E Ratio
$26.99
N/A
Revenue Growth
59.24
6.23
52 Week Low
$24.79
$10.45
52 Week High
$38.32
$18.99

Technical Indicators

Market Signals
Indicator
CTRE
BLCO
Relative Strength Index (RSI) 45.61 60.98
Support Level $35.83 $16.39
Resistance Level $38.18 $17.41
Average True Range (ATR) 0.68 0.46
MACD -0.21 0.06
Stochastic Oscillator 14.86 72.71

Price Performance

Historical Comparison
CTRE
BLCO

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: